Timothy Coughlin

Timothy Coughlin has an estimated net worth of $35.7 Million. This is based on reported shares across multiple companies, which include NEUROCRINE BIOSCIENCES INC, Travere Therapeutics, Inc., FATE THERAPEUTICS INC, aTYR PHARMA INC, and ADC Therapeutics SA.

2014 was Timothy Coughlin's most active year for acquiring shares with 16 total transactions. Timothy Coughlin's most active month to acquire stocks was the month of April. 2015 was Timothy Coughlin's most active year for disposing of shares, totalling 14 transactions. Timothy Coughlin's most active month to dispose stocks was the month of January. 2015 saw Timothy Coughlin paying a total of $3,154,500.00 for 312,000 shares, this is the most they've acquired in one year. In 2015 Timothy Coughlin cashed out on 328,500 shares for a total of $8,670,265.00, their largest year based on trade value.